First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan Deeksha Bhandari15 May 2025 12:42 PM ISTA recent expert group consensus has endorsed the use of vonoprazan for managing refractory gastroesophageal reflux disease (rGERD) in Indian...
Association of Physicians of India Consensus Recommendations for Vonoprazan in Management of Acid Peptic Disorders Dr. Kamal Kant Kohli26 March 2025 11:36 AM ISTThe Association of Physicians of India (API) has recently issued a consensus statement, highlighting vonoprazan as an effective option for managing...
Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIA Farhat Nasim24 Feb 2025 5:12 PM ISTVonoprazan-based GI drugs led new launches, generating Rs 187 crore from 404 brands.
Potassium-Competitive Acid Blockers: AGA Review Offers Insights on Optimal Use in GI Disorders Medha Baranwal27 Jan 2025 8:30 PM ISTUSA: The American Gastroenterological Association (AGA) has released a Clinical Practice Update (CPU) aimed at integrating potassium-competitive acid...
Vonoprazan for PPI-Refractory Functional Dyspepsia among Asian Patients, Study Highlights Deeksha Bhandari27 Jan 2025 11:45 AM ISTA recent study published in the December issue of the Journal of Gastroenterology and Hepatology highlights Vonoprazan's significant effectiveness in...
Indian Pharma Market reaches Rs 19,083 crore in December, Check out top performing brands Farhat Nasim16 Jan 2025 7:43 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has experienced robust growth, reaching a market value of Rs 19,083 crore in December 2024. This...
Spider Web-like mucus pattern after vonoprazan usage- What contributes to its formation? Dr.Niharika Harsha B6 Jan 2025 9:15 AM ISTA recent groundbreaking study published in the journal Biomedical Reports found that vonoprazan (VPZ) usage was associated with a web-like mucus...
10-Day Vonoprazan-Amoxicillin Regimen Matches 14-Day Standard Treatment in H. pylori Eradication, reveals research Medha Baranwal11 Dec 2024 9:00 AM ISTChina: A large-scale study published in the American Journal of Gastroenterology demonstrated that a 10-day regimen of vonoprazan 20 mg twice daily...
Nocturnal Acid Breakthrough and the role of Vonoprazan - Dr Roy Patankar MDTV Bureau12 Nov 2024 10:45 AM ISTNocturnal acid breakthrough (NAB) is defined as a prolonged drop in intra-gastric pH below 4 for over 60 minutes during nighttime hours, a phenomenon...
Hetero Labs Gets CDSCO Panel Nod to Study Vonoprazan Tablet Dr. Divya Colin1 Nov 2024 5:30 PM ISTNew Delhi: Hetero Labs has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Decoding Refractory GERD and the Role of Vonoprazan - Dr Ajay Kumar MD Brand Connect7 Oct 2024 12:45 PM ISTGastroesophageal reflux disease (GERD) occurs when stomach acid flows back into the esophagus due to a weak lower esophageal sphincter. There is no...
Alkem Labs Launches Vonzai, the Next Generation Therapy for APD Management MD Brand Connect1 Oct 2024 11:15 AM ISTAlkem Labs, one of the leaders in the gastro segment with well-known products like PAN, Pan-D, and Obetohep has announced the launch of the...
